Ampio Long Term Debt to Equity vs Debt Current Analysis

AMPE Stock  USD 0.82  0.01  1.23%   
Trend analysis of Ampio Pharm balance sheet accounts such as Other Current Liab of 1.5 M, Total Current Liabilities of 2.6 M or Total Stockholder Equity of 3.2 M provides information on Ampio Pharm's total assets, liabilities, and equity, which is the actual value of Ampio Pharm to its prevalent stockholders. By breaking down trends over time using Ampio Pharm balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.

About Ampio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Ampio Pharm at a specified time, usually calculated after every quarter, six months, or one year. Ampio Pharm Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ampio Pharm and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ampio currently owns. An asset can also be divided into two categories, current and non-current.

Ampio Pharm Balance Sheet Chart

Ampio Pharm Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Ampio Pharm uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Ampio Pharm's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 27.8 K, whereas Other Current Liabilities is forecasted to decline to about 1.5 M.

Total Assets

Total assets refers to the total amount of Ampio Pharm assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ampio Pharm books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Ampio Pharm balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ampio Pharm are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Ampio Pharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ampio Pharm current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.The current year's Enterprise Value Multiple is expected to grow to 0.26, whereas Selling General Administrative is forecasted to decline to about 6.6 M.
 2021 2022 2023 2024 (projected)
Research Development11.9M8.9M2.4M2.3M
Cost Of Revenue1.1M2.1M1.9M3.5M

Ampio Pharm fundamental ratios Correlations

-0.030.580.840.180.840.01-0.54-0.260.130.03-0.150.710.29-0.950.590.970.970.970.090.210.18-0.060.750.560.34
-0.030.75-0.36-0.61-0.04-0.160.10.480.570.610.2-0.320.570.080.12-0.05-0.05-0.02-0.050.2-0.150.52-0.340.37-0.48
0.580.750.25-0.370.52-0.15-0.210.150.480.45-0.040.210.59-0.470.450.520.520.550.010.48-0.080.320.240.59-0.07
0.84-0.360.250.320.630.11-0.33-0.62-0.01-0.52-0.130.640.06-0.830.150.840.840.840.130.220.2-0.590.970.240.42
0.18-0.61-0.370.320.330.31-0.43-0.37-0.9-0.290.140.61-0.78-0.140.140.130.130.09-0.01-0.47-0.06-0.250.23-0.150.84
0.84-0.040.520.630.330.08-0.77-0.09-0.080.15-0.280.810.24-0.640.770.670.670.670.070.250.10.080.530.720.58
0.01-0.16-0.150.110.310.08-0.25-0.22-0.3-0.19-0.20.34-0.150.02-0.17-0.02-0.02-0.030.76-0.160.08-0.180.02-0.230.27
-0.540.1-0.21-0.33-0.43-0.77-0.25-0.140.24-0.230.44-0.85-0.150.39-0.72-0.4-0.4-0.37-0.380.22-0.07-0.21-0.12-0.47-0.47
-0.260.480.15-0.62-0.37-0.09-0.22-0.140.230.74-0.13-0.310.350.290.46-0.31-0.31-0.31-0.1-0.14-0.150.76-0.660.35-0.42
0.130.570.48-0.01-0.9-0.08-0.30.240.230.22-0.11-0.380.87-0.16-0.020.180.180.210.00.430.160.150.040.33-0.73
0.030.610.45-0.52-0.290.15-0.19-0.230.740.220.02-0.080.350.040.63-0.03-0.03-0.03-0.1-0.08-0.090.99-0.590.44-0.25
-0.150.2-0.04-0.130.14-0.28-0.20.44-0.13-0.110.02-0.42-0.340.08-0.31-0.07-0.07-0.07-0.57-0.340.160.01-0.050.01-0.07
0.71-0.320.210.640.610.810.34-0.85-0.31-0.38-0.08-0.42-0.08-0.590.530.60.60.590.41-0.050.11-0.110.470.230.72
0.290.570.590.06-0.780.24-0.15-0.150.350.870.35-0.34-0.08-0.240.280.260.260.290.220.430.170.270.030.59-0.58
-0.950.08-0.47-0.83-0.14-0.640.020.390.29-0.160.040.08-0.59-0.24-0.45-1.0-1.0-0.99-0.1-0.07-0.180.11-0.75-0.38-0.18
0.590.120.450.150.140.77-0.17-0.720.46-0.020.63-0.310.530.28-0.450.450.450.44-0.090.05-0.10.610.040.720.27
0.97-0.050.520.840.130.67-0.02-0.4-0.310.18-0.03-0.070.60.26-1.00.451.01.00.090.130.19-0.110.770.420.2
0.97-0.050.520.840.130.67-0.02-0.4-0.310.18-0.03-0.070.60.26-1.00.451.01.00.090.130.19-0.110.770.420.2
0.97-0.020.550.840.090.67-0.03-0.37-0.310.21-0.03-0.070.590.29-0.990.441.01.00.090.170.2-0.120.780.430.19
0.09-0.050.010.13-0.010.070.76-0.38-0.10.0-0.1-0.570.410.22-0.1-0.090.090.090.09-0.030.11-0.110.0-0.250.02
0.210.20.480.22-0.470.25-0.160.22-0.140.43-0.08-0.34-0.050.43-0.070.050.130.130.17-0.030.03-0.140.360.240.02
0.18-0.15-0.080.2-0.060.10.08-0.07-0.150.16-0.090.160.110.17-0.18-0.10.190.190.20.110.03-0.110.170.09-0.06
-0.060.520.32-0.59-0.250.08-0.18-0.210.760.150.990.01-0.110.270.110.61-0.11-0.11-0.12-0.11-0.14-0.11-0.660.37-0.25
0.75-0.340.240.970.230.530.02-0.12-0.660.04-0.59-0.050.470.03-0.750.040.770.770.780.00.360.17-0.660.20.38
0.560.370.590.24-0.150.72-0.23-0.470.350.330.440.010.230.59-0.380.720.420.420.43-0.250.240.090.370.20.02
0.34-0.48-0.070.420.840.580.27-0.47-0.42-0.73-0.25-0.070.72-0.58-0.180.270.20.20.190.020.02-0.06-0.250.380.02
Click cells to compare fundamentals

Ampio Pharm Account Relationship Matchups

Ampio Pharm fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets14.0M22.9M38.8M13.6M5.7M5.4M
Other Current Liab3.9M1.4M4.4M755K2.1M1.5M
Total Current Liabilities4.3M1.8M5.1M1.2M2.4M2.6M
Total Stockholder Equity6.4M17.5M27.3M11.8M3.4M3.2M
Retained Earnings(184.6M)(200.5M)(217.6M)(233.9M)(242.5M)(230.4M)
Non Current Assets Total5.8M4.4M3.2M259K297.9K283.0K
Common Stock Total Equity11.1K16K19K23K26.5K27.8K
Common Stock Shares Outstanding474.0K595.4K671.5K753.6K810.1K889.4K
Liabilities And Stockholders Equity14.0M22.9M38.8M13.6M5.7M5.4M
Other Stockholder Equity191.1M218.0M244.9M245.7M245.9M135.4M
Total Liab7.6M5.4M11.5M1.8M2.4M2.3M
Common Stock16K19K23K2K1.8K1.7K
Net Debt(5.1M)(16.1M)(33.0M)(12.0M)(3.8M)(4.0M)
Accounts Payable151K186K427K97K111.6K106.0K
Cash6.5M17.3M33.9M12.7M4.1M3.9M
Cash And Short Term Investments6.5M17.3M33.9M12.7M4.1M3.9M
Total Current Assets8.3M18.5M35.6M13.3M5.7M5.4M
Other Current Assets556K696K533K623K1.6M1.7M
Other Liab2.1M2.6M5.8M333K383.0K363.8K
Net Tangible Assets6.4M17.5M27.3M11.8M10.6M12.4M
Property Plant And Equipment Net5.8M4.4M3.2M259K297.9K283.0K
Retained Earnings Total Equity(171.0M)(184.6M)(200.5M)(217.6M)(195.8M)(186.0M)
Non Current Liabilities Total3.3M3.5M6.4M607K698.1K663.1K
Capital Surpluse176.2M191.1M218.0M244.9M281.6M170.7M
Deferred Long Term Liab7.4M2.1M2.6M5.8M6.7M7.1M
Property Plant And Equipment Gross5.8M4.4M3.2M9.5M10.9M5.9M
Property Plant Equipment4.7M3.6M2.6M259K297.9K283.0K
Net Invested Capital6.4M17.5M27.3M11.8M13.6M14.2M
Net Working Capital4.0M16.7M30.5M12.1M14.0M13.6M

Pair Trading with Ampio Pharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ampio Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ampio Pharm will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ampio Stock

  0.62MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Ampio Stock

  0.6DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.53MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.53MESO Mesoblast TrendingPairCorr
  0.47MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.44TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Ampio Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ampio Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ampio Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ampio Pharm to buy it.
The correlation of Ampio Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ampio Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ampio Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ampio Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ampio Pharm is a strong investment it is important to analyze Ampio Pharm's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ampio Pharm's future performance. For an informed investment choice regarding Ampio Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Ampio Stock analysis

When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Ampio Pharm's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ampio Pharm. If investors know Ampio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ampio Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.70)
Return On Assets
(0.47)
Return On Equity
(0.92)
The market value of Ampio Pharm is measured differently than its book value, which is the value of Ampio that is recorded on the company's balance sheet. Investors also form their own opinion of Ampio Pharm's value that differs from its market value or its book value, called intrinsic value, which is Ampio Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ampio Pharm's market value can be influenced by many factors that don't directly affect Ampio Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ampio Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ampio Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ampio Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.